Journal of Comparative Effectiveness Research

Papers
(The H4-Index of Journal of Comparative Effectiveness Research is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Healthcare resource utilization and costs among patients with alpha-1 antitrypsin deficiency with liver and/or lung disease: a longitudinal retrospective study in the USA107
The economic cost of racial disparities in patients undergoing cardiac valve repair or replacement88
Does off-hours endoscopic hemostasis affect outcomes of nonvariceal upper gastrointestinal bleeding?43
Letter in reply39
Corrigendum38
Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost–effectiveness analysis33
The views of teenagers with obesity, their caregivers, and doctors: a plain language summary of the ACTION Teens global survey27
Journal of Comparative Effectiveness Research : 2022 year in review23
Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study22
Advanced or metastatic biliary tract cancer in Japan: a study using the Japan Medical Data Center payer claims database22
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 1022
A plain language summary of the long-term relugolix combination therapy study for uterine fibroids21
Systematic literature review of evidence in amyloid light-chain amyloidosis20
Meta-analysis of visual pretreatment for the prevention of emergence delirium in children undergoing ophthalmic surgery19
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer17
Breast-conserving surgery versus mastectomy for older women with triple-negative breast cancer: population-based study17
Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionals17
Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making17
0.041652917861938